- Home
- NSYS vs NRSN Comparison
NSYS vs NRSN Comparison
Compare NSYS & NRSN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NSYS
- NRSN
- Stock Information
- Founded
- NSYS 1981
- NRSN 2017
- Country
- NSYS United States
- NRSN Israel
- Employees
- NSYS N/A
- NRSN N/A
- Industry
- NSYS Industrial Machinery/Components
- NRSN Biotechnology: Pharmaceutical Preparations
- Sector
- NSYS Technology
- NRSN Health Care
- Exchange
- NSYS Nasdaq
- NRSN Nasdaq
- Market Cap
- NSYS 29.0M
- NRSN 26.0M
- IPO Year
- NSYS N/A
- NRSN 2021
- Fundamental
- Price
- NSYS $9.19
- NRSN $0.91
- Analyst Decision
- NSYS
- NRSN Hold
- Analyst Count
- NSYS 0
- NRSN 1
- Target Price
- NSYS N/A
- NRSN N/A
- AVG Volume (30 Days)
- NSYS 4.8K
- NRSN 172.3K
- Earning Date
- NSYS 03-31-2025
- NRSN 04-08-2025
- Dividend Yield
- NSYS N/A
- NRSN N/A
- EPS Growth
- NSYS N/A
- NRSN N/A
- EPS
- NSYS N/A
- NRSN N/A
- Revenue
- NSYS $128,133,000.00
- NRSN N/A
- Revenue This Year
- NSYS N/A
- NRSN N/A
- Revenue Next Year
- NSYS N/A
- NRSN N/A
- P/E Ratio
- NSYS N/A
- NRSN N/A
- Revenue Growth
- NSYS N/A
- NRSN N/A
- 52 Week Low
- NSYS $8.50
- NRSN $0.51
- 52 Week High
- NSYS $19.15
- NRSN $2.25
- Technical
- Relative Strength Index (RSI)
- NSYS 35.74
- NRSN 29.02
- Support Level
- NSYS $8.50
- NRSN $1.00
- Resistance Level
- NSYS $10.05
- NRSN $1.13
- Average True Range (ATR)
- NSYS 0.34
- NRSN 0.08
- MACD
- NSYS -0.04
- NRSN -0.02
- Stochastic Oscillator
- NSYS 36.78
- NRSN 8.23
About NSYS Nortech Systems Incorporated
Nortech Systems Inc is a United States-based electronic manufacturing services company. It offers value-added engineering, technical and manufacturing services and support including project management, design, testing, prototyping, manufacturing, supply chain management, and post-market services. The company's manufacturing and engineering services include complete medical devices, printed circuit board assemblies, wire and cable assemblies, and complex higher-level electro-mechanical assemblies. It operates in the Medical, Aerospace, Defense and Industrial markets with key revenue coming from Medical device and product manufacturing and related engineering services.
About NRSN NeuroSense Therapeutics Ltd.
NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases, these diseases include Amyotrophic Lateral Sclerosis, or ALS, Alzheimer's disease and Parkinson's disease, among others. Its product candidate, PrimeC, is a novel extended-release, or ER, oral formulation of a fixed dose combination of two generic FDA-approved drugs, ciprofloxacin and celecoxib, combined in a specific ratio.